| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443950A2 A plant extract active as an immunostimulating agent |
| 08/11/2004 | EP1443944A1 Pharmaceutical applications of hyaluronic acid preparations |
| 08/11/2004 | EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443931A1 Methods for treating neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443921A1 PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO 5.2.1.0 sp 2.6 /sp -DEC-9-YL XANTHOGENATE AND MEDICAMENTS THEREFROM |
| 08/11/2004 | EP1443915A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443820A1 Composition and method for treating graft-versus-host disease |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1056714B1 Phenylalanine derivatives as inhibitors of alpha4 integrins |
| 08/11/2004 | EP0977859B1 The neurotrophic factor nnt-1 |
| 08/11/2004 | EP0779922B1 Modified human c3 proteins |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520423A Epitopes or mimotopes derived from C-eqsilon-3, or C-epsilon-4 domains of ige, antagonists thereof, and their thera peutic uses |
| 08/11/2004 | CN1520421A Recombinant tumor specific antibody and use thereof |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520408A Piperazine compounds |
| 08/11/2004 | CN1520402A Unsymmetrical cyclic diamine compound |
| 08/11/2004 | CN1520400A Cyclic diamine compounds bearing six-membered cyclic groups |
| 08/11/2004 | CN1520395A Cycloalkenone derivative |
| 08/11/2004 | CN1520318A Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520295A Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/11/2004 | CN1520293A 3-flworo-pyrrolidines as antidiabetic agents |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |
| 08/11/2004 | CN1520285A Tablet comprising cetirizine and pseudoephedrine |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519238A Technique for preparing salt of nosimidazole and combination of medication |
| 08/11/2004 | CN1161379C Novel peptides derived from autoantigent for use in immunitherapy of autoimmune diseases |
| 08/11/2004 | CN1161360C Tetrazole-containg rapamycin analogs with shortened half-lives |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161153C Immobilized isomerous tumor vaccine and its preparing process |
| 08/11/2004 | CN1161150C Pharmaceutical compositions |
| 08/11/2004 | CN1161129C I(ex vivo) treatment of allogeneic and xanogeneic T-cells with gp39 antagonists |
| 08/11/2004 | CN1161119C Lefunomide plaster and its prepn. method |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774142 May be administered along with rutin, a rutin congener and/or a rutin derivative. |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774118 Therapeutic use of CIS-element decoys in vivo |
| 08/10/2004 | US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 08/10/2004 | US6773916 Administering sub-immunological sized antigen-binding molecule (fc/fv fragments) |
| 08/10/2004 | US6773728 Herbal composition of blend of active components prepared from murrya koenigii and piper betle useful for blocking of 5 lipoxygenase activity leading to the inhibition of leukotriene synthesis, suppression of interleukin-4 production, and enhancement of gamma interferon release |
| 08/10/2004 | US6773708 Suppression of excessive th1 and stimulation of th2 cell mediated immune responses |
| 08/10/2004 | US6773705 Restoring nf kappa b activity |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | US6773695 Modulation of allergic response |
| 08/10/2004 | CA2187024C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 08/10/2004 | CA2129101C Synthetic haemophilus influenzae conjugate vaccine |
| 08/05/2004 | WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 08/05/2004 | WO2004065395A1 Thienopyridazinones and their use in modulation of autoimmune disease |
| 08/05/2004 | WO2004065394A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 08/05/2004 | WO2004065365A1 8-azaprostaglandin derivatives and medicinal uses thereof |
| 08/05/2004 | WO2004064912A1 An otorhinological delivery device |
| 08/05/2004 | WO2004064863A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway |
| 08/05/2004 | WO2004064860A1 Use of tff2, or agents inducing tff2, in the therapy of allergies |
| 08/05/2004 | WO2004064857A1 Drugs containing galectin 9 |
| 08/05/2004 | WO2004064853A1 Cordyceps capsule and method for preparation thereof |
| 08/05/2004 | WO2004064852A1 Standardised steroid saponin mixture, a method of its obtaining and application |
| 08/05/2004 | WO2004064787A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064717A2 Cop 1 for treatment of inflammatory bowel diseases |
| 08/05/2004 | WO2004029192A3 Producing method of tien hsien liquid |
| 08/05/2004 | WO2004028243A3 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004012746A3 New uses for inhibitors of inosine monophosphate dehydrogenase |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003045979A3 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152768 NO-synthase inhibitors comprising ascorbyl 2-hexadecanoate |
| 08/05/2004 | US20040152762 Oxidation resistance; from hesperidin using Aspergillus fermentation |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152735 NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152707 Analgesics; anxiolytic agents; antihistamines; antitussive agents; antidepressants; alcoholism |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |